CELL THERAPY - CELLULAR & TISSUE XENOTRANSPLANTATION: Challenges, Progress and Current Applications. The team of researchers who collaborated with Dr. Chan, pioneer of these studies, has produced a document with a strong bibliographic depth for those who wish to explore the content. As we read in the preface: "For more than a century, xenotransplantation has been viewed as a potential solution to address the scarcity of human organs and tissue which are available for allotransplantation. However, due to numerous obstacles, including immunological rejection, regulatory restrictions, and ethical considerations; the progress of xenotransplantation has been stagnant and largely trapped in the preclinical stage. This book explores the challenges surrounding the field of xenotransplantation, looks into possible strategies to overcome them and discusses the potential and future of this field". Accurate images make it a very informative text. Prof. Dato' Sri Dr. Mike K.S. Chan, 62 yo Malaysian, Chairman of European Wellness Biomedical Group is a Scientist, Researcher, Author, and Educator in Stem Cells, Immunology and Bioregenerative Medicine for 39 years in Europe. He owns 40+ medical wellness, hospitals, and centres worldwide. Authored about 40+ scientific books and 90+ publications in the USA and the UK. Holds 40+ international patents in stem cells, immunology and biotechnology. He, - Board member, Head of Scientific Committee for Regenerative Medicine and Asian Chairman of ESAAM (European Society of Preventative, Regenerative and Anti-Aging Medicine) est. 2003 - Host the Society's Asian Chairman; Associate Professor of AASCP-USA (American Academy of Stem Cell Physicians) - Chairman of A4M-USA (American Academy of Anti-Aging Medicine) for Thailand - Chairman of Japan's Medical Association for Regenerative Medicine, MMJ (Multi-Dimensional Holistic Medical Team Japan) - Senator of BWA-Germany (Federal Association for Economic Development & Foreign Trade for China, Indonesia and Malaysia) - Healthcare advisor to renowned SSP (Swiss Strategic Partners), Zurich, which services Fortune 500 companies Chairman / Founder of the world's first stem cells association of the world, namely IASCT (International Association of Stem Cell Transplantation), USA. Chairman of the IACT (International Association of Cell Therapy), Switzerland. Appeared in more than 30 front covers worldwide. 30+ Multiple Award Winner for Invention & Innovations, Quality & Top Entrepreneur Leadership. 1,000+ lectures in international scientific & medical anti-ageing conferences. Prof. Dato Sri Dr. Michelle B.F. Wong, ND, PhD is a scientist, researcher and educator actively involved in research and development (R&D) work on stem cells focusing on Fetal Precursor Stem-Cell Therapy. She is the Co-Founder/Senior Technical Advisor and Researcher in FCTI Inc., specialising in Stem cell Research and Bio-Regenerative Medicine for more than three decades. A prominent speaker, Michelle Wong presents at educational programs and global conferences on stem cells, cell therapy and biological medicine for physicians and healthcare practitioners worldwide.